-
IDweek2023 | A Comprehensive Examination of Racial, Ethnic, and Gender Disparities in Sepsis Treatment and Outcomes
IDweek2023 A Comprehensive Examination of Racial, Ethnic, and Gender Disparities in Sepsis Treatment and Outcomes Sepsis, an extreme response to infection that can lead to life-threatening organ dysfunction, poses a significant global health issue. Despite advancements in healthcare, disparities in the treatment and outcomes of sepsis persist, particularly in relation to race, ethnicity, and gender.…
-
IDweek2023 | A Comprehensive Review of Outcomes in Intravenous to Oral Antimicrobial Therapy in Uncomplicated β-hemolytic Streptococcus Bloodstream Infections in Immunocompromised Individuals
IDweek2023 A Comprehensive Review of Outcomes in Intravenous to Oral Antimicrobial Therapy in Uncomplicated β-hemolytic Streptococcus Bloodstream Infections in Immunocompromised Individuals IDweek2023 A Comprehensive Review of Outcomes in Intravenous to Oral Antimicrobial Therapy in Uncomplicated β-hemolytic Streptococcus Bloodstream Infections in Immunocompromised Individuals
-
IDweek2023 | A Comprehensive Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) versus Dolutegravir/Lamivudine (DTG/3TC) in HIV Treatment
IDweek2023 A Comprehensive Analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) versus Dolutegravir/Lamivudine (DTG/3TC) in HIV Treatment In the relentless battle against HIV, the advent of antiretroviral therapy (ART) has marked a significant turning point. The development and introduction of drug regimens have revolutionized HIV treatment, transforming HIV from a fatal illness into a manageable chronic condition. However,…
-
IDweek2023 | The Revolutionary Shift in HIV Management: An In-Depth Analysis of Cabotegravir + Rilpivirine Long-Acting Treatment Versus Traditional Oral Antiretroviral Therapy
IDweek2023 The Revolutionary Shift in HIV Management: An In-Depth Analysis of Cabotegravir + Rilpivirine Long-Acting Treatment Versus Traditional Oral Antiretroviral Therapy In the ever-evolving world of medicine, the ultimate goal has consistently been to enhance patient adherence and improve treatment outcomes. This is particularly apparent in the management of HIV, where antiretroviral therapy (ART) has…
-
IDweek2023 | Exploring the Consequences of Low-Level Viremia Among Women with HIV
IDweek2023 Exploring the Consequences of Low-Level Viremia Among Women with HIV Understanding the dynamics of HIV infection is critical for managing and controlling the disease. A vital aspect of this understanding is the awareness of Low-Level Viremia (LLV), a condition experienced by about a third of people living with HIV. Despite its prevalence, there is…
-
IDweek2023 | Hepatitis B Reactivation in HIV Patients: A Comprehensive Study of Antiretroviral Therapy’s Role
IDweek2023 Hepatitis B Reactivation in HIV Patients: A Comprehensive Study of Antiretroviral Therapy’s Role Hepatitis B, a viral infection that primarily affects the liver, can lead to serious complications, such as cirrhosis and hepatocellular carcinoma. In individuals living with HIV, the situation is further complicated since they face the risk of Hepatitis B reactivation -…
-
IDweek2023 | A Comprehensive Exploration of At-Home vs. In-Clinic Administration of Cabotegravir and Rilpivirine Long-Acting: An In-depth Analysis of an Implementation Science Trial
IDweek2023A Comprehensive Exploration of At-Home vs. In-Clinic Administration of Cabotegravir and Rilpivirine Long-Acting: An In-depth Analysis of an Implementation Science Trial The approval of the long-acting injectable cabotegravir-rilpivirine in January 2021 marked a significant milestone in the medical realm. This dual-drug regimen has revolutionized the approach to HIV treatment by providing an effective and convenient…
-
IDweek2023 | A Deep Dive into the Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Insights from the OPERA® Cohort.
IDweek2023 A Deep Dive into the Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Insights from the OPERA® Cohort. The world of HIV (Human Immunodeficiency Virus) management has seen remarkable strides over the years, with the advent of antiretroviral therapy (ART) significantly improving the quality of…
Connecting Medical Expertise through Media